METTL3 Is Associated With the Malignancy of Esophageal Squamous Cell Carcinoma and Serves as a Potential Immunotherapy Biomarker

Por Yubin Zhou, Songhe Guo, Yiqiu Li, Fangfang Chen, Yaxian Wu, Yi Xiao, Jun An
Publicado em 2022-04-01